Orkambi and Symkevi have been rejected by the Scotland Medicines Consortium (SMC) due to their conclusion that the costs outweigh the benefits.
orkambi
-
August 16, 2019
-
December 03, 2018
Australia provides reimbursement for cystic fibrosis medicine.